The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder

被引:40
作者
Fuller, TC [1 ]
Fuller, A [1 ]
机构
[1] Univ Utah, Sch Med, Histocompatibil & Immunogenet Lab, Dept Pathol, Salt Lake City, UT 84132 USA
关键词
D O I
10.1097/00007890-199907270-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The genetic basis for control of alloantibody responses against foreign HLA histocompatibility antigens has never been delineated. The most likely postulate would be that HLA class II alloantigens of the beast regulate the response through their ability to present processed HLA allopeptide fragments for the cognate interaction between CD4(+) T lymphocytes and B lymphocytes that leads to IgG antibody synthesis. Methods. We have analyzed our allosensitized transplant patient population with regard to humoral responsiveness to a serologically defined public HLA class I epitope, Bw4. Peptides representing the linear sequence of the Bw4 epitope (amino acids 74-86) and the alternative Bw6 epitope were synthesized and assayed for binding to a panel of HLA homozygous lymphoblastoid B cells using a quantitative fluorescence binding assay. Results. We found that 73% of patients who have produced a HLA-Bw4-specific alloantibody express either the HLA-DRB1*01 or HLA-DRB1*03 alloantigen; 19% of the remaining responders expressed HLA-DRB1*04. Analysis of the United Network for Organ Sharing Transplant Registry indicated that the survival of cadaver renal allografts mismatched for Bw4 was significantly compromised in sensitized DRB1*01(+) or DRB1*03(+) recipients (P < 0.01). In vitro, the Bw4 peptide bound strongly to DRB1*01(+) and DRB1*03(+) lymphoblastoid B cells; no similar binding was observed with Bw6 peptide, These findings were confirmed using murine fibroblast lines transfected with HLA-DR alpha/beta genes and by solid-phase enzyme-linked immunosorbent assay using purified HLA-DR alloantigen. Conclusions. We conclude that there are at least two human Ir genes, HLA-DRB1*01 and HLA-DRB1*03, that confer a high risk for both humoral allosensitization and renal allograft failure in situations of HLA-Bw4 incompatibility. These findings may be of future benefit in devising new antigen matching strategies for reducing the risk of humoral HLA allosensitization and chronic allograft rejection.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 60 条
[1]   MILD PROCEDURE FOR SOLID-PHASE PEPTIDE-SYNTHESIS - USE OF "FLUORENYLMETHOXYCARBONYLAMINO-ACIDS [J].
ATHERTON, E ;
FOX, H ;
HARKISS, D ;
LOGAN, CJ ;
SHEPPARD, RC ;
WILLIAMS, BJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1978, (13) :537-539
[2]   Antigen processing and presentation in transplantation [J].
Auchincloss, H ;
Sultan, H .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) :681-687
[3]   INDIVIDUAL VARIATION IN ALLORESPONSIVENESS AND THE MOLECULAR-BASIS OF ALLORECOGNITION [J].
BATCHELOR, JR ;
KAMINSKI, E ;
LOMBARDI, G ;
GOLDMAN, JM ;
LECHLER, RI .
HUMAN IMMUNOLOGY, 1990, 28 (02) :96-103
[4]   HLA GENE AMPLIFICATION AND HYBRIDIZATION ANALYSIS OF POLYMORPHISM - HLA MATCHING FOR BONE-MARROW TRANSPLANTATION OF A PATIENT WITH HLA-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY SYNDROME [J].
BAXTERLOWE, LA ;
HUNTER, JB ;
CASPER, JT ;
GORSKI, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :613-618
[5]  
BENICHOU G, 1994, J IMMUNOL, V153, P938
[6]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[7]   Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation [J].
Benichou, G ;
Tam, RC ;
Soares, LRB ;
Fedoseyeva, EV .
IMMUNOLOGY TODAY, 1997, 18 (02) :67-71
[8]   DISTINCT H-2-LINKED IR-GENES CONTROL BOTH ANTIBODY AND T-CELL RESPONSES TO DIFFERENT DETERMINANTS ON THE SAME ANTIGEN, MYOGLOBIN [J].
BERZOFSKY, JA ;
RICHMAN, LK ;
KILLION, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (08) :4046-4050
[9]   PROCESSED MHC CLASS-I ALLOANTIGEN AS THE STIMULUS FOR CD4+ T-CELL DEPENDENT ANTIBODY-MEDIATED GRAFT-REJECTION [J].
BRADLEY, JA ;
MOWAT, AM ;
BOLTON, EM .
IMMUNOLOGY TODAY, 1992, 13 (11) :434-438
[10]   INDIVIDUAL-DIFFERENCES IN THE CYTOTOXIC T-LYMPHOCYTE RESPONSE IN MAN TO PUBLIC HLA DETERMINANTS [J].
BREURVRIESENDORP, BS ;
IVANYI, P .
CELLULAR IMMUNOLOGY, 1986, 103 (02) :252-271